Cargando…
Time to Mammographic Density Decrease After Exposure to Tamoxifen
Mammographic density change has proven to be a reliable proxy for tamoxifen therapy response. The primary aim of this study was to identify time to tamoxifen-induced mammographic density change. We also analyzed side effects and adherence to therapy. In all, 42 women were randomized to 10 or 20 mg o...
Autores principales: | Bäcklund, Magnus, Eriksson, Mikael, Hammarström, Mattias, Thoren, Linda, Bergqvist, Jenny, Margolin, Sara, Hellgren, Roxanna, Wengström, Yvonne, Gabrielson, Marike, Czene, Kamila, Hall, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256030/ https://www.ncbi.nlm.nih.gov/pubmed/35605013 http://dx.doi.org/10.1093/oncolo/oyac104 |
Ejemplares similares
-
Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial
por: Eriksson, Mikael, et al.
Publicado: (2021) -
Topical Endoxifen for Mammographic Density Reduction—A Randomized Controlled Trial
por: Bäcklund, Magnus, et al.
Publicado: (2022) -
Predictors of mammographic microcalcifications
por: Azam, Shadi, et al.
Publicado: (2020) -
Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women
por: Hammarström, Mattias, et al.
Publicado: (2023) -
Mammographic microcalcifications and risk of breast cancer
por: Azam, Shadi, et al.
Publicado: (2021)